Research On The Dry Powder Inhalation Drug Manufacture JV Company's Product Development Strategy

According to the estimation data from WHO, about 275 million patients are suffering from asthma all over the world. In recent years, the morbidity of asthma attack increases significantly, especially for the population of urban children. In China, the population of patients with respiratory disease also increases with rapid speed. However, due to the expensive treatment cost, only small portion of patients seek for treatment. If drugs with low cost can be provided in the market, the rate of patients seeking treatment can be effectively promoted.Nevertheless, the formulation of inhalation product required dedicated technology and the pharmaceutical development is also challenging. The inhalation devices are supposed to deliver the drugs to lung. The effect of drugs is closely related to the performance of devices. The delivery of active ingredients and the ratio of each active ingredient must be precise. In addition, the devices must be repeatable as for the time proceeds. That means the performance of devices and the formulation for each inhalation must be stable. As a result, the problems in powder inhalation devices development should be addressed.At the same time we should also invest the research on drug substance synthesis and manufacture process for formulation. By building the research lab and fortifying cooperation, we could solve the technology problems with various scientific methods. In order to achieve the goal of industrialization, we should address the relevant problems in finance, human resources, market, manufacture site and facilities.In this article, we discussed a pharmaceutical JV company jointed by a China government owned company and a British research organization. This company plans to produce anti-asthma drug products. In reliance with the high-end devices, pharmaceuticals development system of British company and the expectation of domestic and international market, as well as by the incorporation of advanced inhalation and pharmaceutical technology, we can build a corporation to produce anti-asthma powder inhalation drugs. We can break the monopoly status of import drugs by the production of drugs with international level quality and domestic level cost. The JV company would serves the patients with respiratory diseases and achieve the future development in both domestic and international market.Guided by the strategy management theory, by taking advantage of strategy analysis method such as PEST analysis, SWOT analysis model and Michael Porter five forces model, we can have thorough and clearly understanding towards the inside and outside circumstances of the company. We could also have explicit understanding regard the advantages, disadvantages, opportunities and potential risks. As a result, the development direction and strategy arise from the previous analysis will be much more effective to boost the growth of the company.